Press Releases
Demand for Chemotherapy-Induced Myelosuppression Treatment in the U.S. to Rising Cancer Treatment Volumes
The United States market for treatments addressing chemotherapy-induced myelosuppression (CIM) is on a robust upward trajectory, driven by rising cancer incidences and advancements in supportive care therapies.
FMI
February 10, 2026